Axert and Chills - a phase IV clinical study of FDA data

Summary:

Chills is reported as a side effect among people who take Axert (almotriptan malate), especially for people who are female, 50-59 old, also take Tylenol, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Chills when taking Axert. It is created by eHealthMe based on reports of 1,106 people who have side effects when taking Axert from the FDA, and is updated regularly.

What is Axert?

Axert has active ingredients of almotriptan malate. It is often used in migraine. eHealthMe is studying from 1,175 Axert users. Check the latest studies of Axert.

What is Chills?

Chills (felling of cold) is found to be associated with 2,567 drugs and 3,472 conditions by eHealthMe. Check the latest studies of Chills.

On Jul, 13, 2026

1,106 people reported to have side effects when taking Axert.
Among them, 14 people (1.27%) have Chills.

Among these 14 people:

What is the gender of people who have Chills when taking Axert? *

female: 92.86 %
male: 7.14 %

What is the age of people who have Chills when taking Axert? *

What are other drugs people take besides Axert? *

What are other side effects people have besides Chills? *

Fever: 8 people, 57.14%
Weakness: 8 people, 57.14%
Headache (pain in head): 7 people, 50.00%
Fatigue (feeling of tiredness): 6 people, 42.86%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 42.86%
Rashes (redness): 5 people, 35.71%
Back Pain: 5 people, 35.71%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 35.71%
Feeling Hot: 4 people, 28.57%
Facial Paralysis (loss of function of face muscle): 4 people, 28.57%

What are the existing conditions these people have? *

Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 4 people, 28.57%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 28.57%
Depression: 3 people, 21.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Pulmonary Thrombosis (scarring in the lungs): 1 person, 7.14%
Osteoporosis (bones weak and more likely to break): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Axert and have Chills?

- Check whether Chills is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Axert:

Axert (1,175 reports)

Chills treatments and more:

Chills (145,628 reports)

Browse all side effects of Axert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chills:

Chills (2,567 drugs)

Browse all the conditions that are associated with Chills:

Chills (3,472 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on almotriptan malate (the active ingredients of Axert) and Axert (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.